Healius stock heads toward October 22 AGM as losses narrow 27.00 percent
Published on 10/17/2026 at 20:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnnual meeting and valuation
- Healius is scheduled to hold its annual meeting on October 22, 2026.
- Market capitalization stood at AUD 272.3 million on October 16, 2026.
- Healius stock cost EUR 0.22 at Lang & Schwarz on October 16, 2026, 1.83 percent above the Frankfurt close of October 15, 2026.
- Healius had a price-to-earnings ratio of minus 0.66 on October 16, 2026.
Healius stock (ISIN AU0000033359) is heading toward its annual meeting on October 22, 2026, while its fiscal year 2026 net loss narrowed 27.00 percent to AUD 408.9 million, according to Simply Wall St. The latest Frankfurt quote stood at EUR 0.22 on October 16, 2026 at 8:04 a.m. CEST, 1.83 percent above the Frankfurt close of October 15, 2026.
Market value remains modest
Healius had a market capitalization of AUD 272.3 million on October 16, 2026. The company describes itself as one of Australia's largest pathology providers, with one in every three pathology samples tested in its laboratories, according to its investor-relations page.
Its fiscal year 2026 revenue rose 2.10 percent to AUD 1.37 billion, while the net loss narrowed from AUD 563.0 million in fiscal year 2025 to AUD 408.9 million in fiscal year 2026, according to Healius. The comparison points to improving loss metrics alongside limited revenue growth.
Price position on October 16
On the ASX, Healius last stood at AUD 0.38 on October 16, 2026 at 4:15 p.m. AEDT. The 52-week range was AUD 0.30 to AUD 1.07, placing the latest home-market price 64.49 percent below the high and 26.67 percent above the low.
The euro quotation ranged from EUR 0.2160 to EUR 0.2360 during the October 16 session. This gives investors in Germany a narrow trading frame around the EUR 0.22 Frankfurt price.
Valuation and the next date
The price-to-earnings ratio was minus 0.66 and the market capitalization was AUD 272.3 million on October 16, 2026. Simply Wall St lists Healius's annual meeting for October 22, 2026.
Comparison with peers
Healius: plus 1.83 percent, P/E minus 0.66, market capitalization AUD 272.3 million
Sonic Healthcare (ASX, AUD): plus 0.43 percent, P/E 15.10, market capitalization AUD 9.2 billion
Australian Clinical Labs (ASX, AUD): plus 0.70 percent, P/E 23.20, market capitalization AUD 533.4 million
Frankfurt quote sets the frame
Healius traded at EUR 0.22 in Frankfurt on October 16, 2026 at 8:04 a.m. CEST, 1.83 percent above the Frankfurt close of October 15, 2026. The October 22 annual meeting is the next dated corporate event.
Healius stock facts
- Company: Healius Limited
- ISIN: AU0000033359
- Ticker: HLS
- Primary exchange: ASX
- Price Frankfurt (as of October 16, 2026, 8:04 a.m. CEST): EUR 0.22
- Change versus Frankfurt close: plus 1.83 percent
- Market capitalization: AUD 272.3 million (as of October 16, 2026)
- 52-week range: AUD 0.30-AUD 1.07 (as of October 16, 2026)
- Sector / Industry: Healthcare / Medical diagnostics and research
- Next annual meeting: October 22, 2026
Market context: Market report S&P/ASX 200.
